Role of macrophages and lymphocytes in morphogenesis of features of blood vessel in patients with metabolic syn-drome complicated by stroke.

Authors

  • N. Ya. Chuiko Івано-Франківський національний медичний університет, Івано-Франківськ, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2013.3.112-116

Keywords:

macrophages, lymphocytes, atherosclerosis, metabolic syndrome

Abstract

Background. The main morphological substrate of arterial disease in the metabolic syndrome is atherosclerosis, which morphogenesis is studied insufficiently. Objective. To estimate the role of macrophages and lymphocytes in the morphogenesis of changes of cerebral arteries in patients with metabolic syndrome complicated by ischemic and hemorrhagic stroke. Methods. We investigated brain vessels of 30 deaths from ischemic stroke, 30 - with hemorrhagic stroke on the background of metabolic syndrome and 20 died of causes unrelated to cerebrovascular disease (control group). Samples were investigated with histological and immunocytochemical methods; in particular the expression of CD4, CD8, CD20 and CD68 markers was examined. Results. The amount of CD68 positive cells in the area of formation of atherosclerosis lesions was 16,68±1,82 in group with ischemic stroke and 14,56±1,28 in group with hemorrhagic stroke. The number of Т-helpers (CD4+) in the area of formation of atherosclerosis lesions was 11,18±1,76 in group with ischemic stroke and 10,32±1,24 in group with hemorrhagic stroke. The number of Т-suppressors (CD8+) was 8,56±1,16 and 9,12±1,64, respectively. The amount of В-lymphocytes (CD20+) was - 5,34±0,86 with ischemic stroke and 6,04±1,14 with hemorrhagic stroke. Conclusion. The presence of macrophages, helper and suppressor lymphocytes in vessel wall with atherosclerosis in patients with ischemic and hemorrhagic stroke as complication of metabolic syndrome confirm the role of these cells in morphogenesis of changes in brain arteries at metabolic syndrome.

References

  1. Mychka VB, Chazova IE. [Metabolic syndrome]. Sistemniye gipertenzii. 2009; (1): 50-3. Russian.
  2. Bobryshev YuV, Karagodin VP, Kovalevskaya ZhI, Shapyrina YeV, Kargapolova YuM, Galaktionova DYu, Saliamov VI, Orekhov AN. [Cellular mechanisms of atherosclerosis: innate immunity and inflammation]. In: Ilyinskikh NN, editor. Fundamentalniye nauki i praktika [Fundamental sciences and practice]: The proceedings of the 3rd International teleconference ‘Problems and prospects of modern medicine, biology and ecology’; 2010 Oct-Nov]. Tomsk; 2010. Vol.1, No 4. p. 140-8. Russian.
  3. Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, Keren G, George J. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):893-900. Epub 2007 Feb 1. Cited in: PubMed; PMID: 17272749.
  4. Soliman A, Kee P. Experimental models investigating the inflammatory basis of atherosclerosis. Curr Atheroscler Rep. 2008 Jun;10(3):260-71. Cited in: PubMed; PMID: 18489855.
  5. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008 Oct;8(10):802-15. doi: 10.1038/nri2415. Cited in: PubMed; PMID: 18825131.
  6. Yan ZQ, Hansson GK. Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev. 2007 Oct;219:187-203. Cited in: PubMed; PMID: 17850490.
  7. Shibata N, Glass CK. Regulation of macrophage function in inflammation and atherosclerosis. J Lipid Res. 2009 Apr;50 Suppl:S277-81. doi: 10.1194/jlr.R800063-JLR200. Epub 2008 Nov 5. Cited in: PubMed; PMID: 18987388; PMCID: PMC2674700.
  8. Gordon S. Macrophage heterogeneity and tissue lipids. J Clin Invest. 2007 Jan;117(1):89-93. Cited in: PubMed; PMID: 17200712; PMCID: PMC1716225.
  9. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008 Dec;8(12):958-69. doi: 10.1038/nri2448. Cited in: PubMed; PMID: 19029990; PMCID: PMC2724991.
  10. Gotsman I, Gupta R, Lichtman AH. The influence of the regulatory T lymphocytes on atherosclerosis. Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2493-5. Epub 2007 Sep 27. Cited in: PubMed; PMID: 17901372.
  11. Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T-cell immunity in atherosclerosis. Trends Cardiovasc Med. 2007 May;17(4):113-8. Cited in: PubMed; PMID: 17482092.
  12. Aukrust P, Otterdal K, Yndestad A, Sandberg WJ, Smith C, Ueland T, Øie E, Damås JK, Gullestad L, Halvorsen B. The complex role of T-cell-based immunity in atherosclerosis. Curr Atheroscler Rep. 2008 Jun;10(3):236-43. Cited in: PubMed; PMID: 18489852.
  13. Mallat Z, Taleb S, Ait-Oufella H, Tedgui A. The role of adaptive T cell immunity in atherosclerosis. J Lipid Res. 2009 Apr;50 Suppl:S364-9. doi: 10.1194/jlr.R800092-JLR200. Epub 2008 Dec 2. Cited in: PubMed; PMID: 19050311; PMCID: PMC2674704.
  14. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006 Jul;6(7):508-19. Epub 2006 Jun 16. Cited in: PubMed; PMID: 16778830.

How to Cite

Chuiko, N. Y. (2013). Role of macrophages and lymphocytes in morphogenesis of features of blood vessel in patients with metabolic syn-drome complicated by stroke. Морфологія / Morphologia / Morfologìâ, 7(3), 112–116. https://doi.org/10.26641/1997-9665.2013.3.112-116

Issue

Section

Статті